Art

J-GLOBAL ID：201502201531425141   Reference number：15A1263778

Cyclosporine A combined with low-dose corticosteroid treatment in patients with idiopathic pulmonary fibrosis

特発性肺線維症患者における低用量コルチコステロイドとサイクロスポリンAの併用効果

Author (10)： MIYAZAKI Yasunari (Tokyo Medical and Dental Univ., Tokyo, JPN) ,  AZUMA Arata (Nippon Medical School, Tokyo, JPN) ,  INASE Naohiko (Tokyo Medical and Dental Univ., Tokyo, JPN) ,  TANIGUCHI Hiroyuki (Tosei General Hospital, Aichi, JPN) ,  OGURA Takashi (Kanagawa Cardiovascular and Respiratory Center, Yokohama, JPN) ,  INOUE Eisuke (National Center for Child Health and Dev., Tokyo, JPN) ,  TAKEUCHI Masahiro (Kitasato Univ., Tokyo, JPN) ,  YOSHIZAWA Yasuyuki (Tokyo Medical and Dental Univ., Tokyo, JPN) ,  SUGIYAMA Yukihiko (Jichi Medical Univ., Tochigi, JPN) ,  KUDOH Shoji (Fukujuji Hospital, Anti-Tuberculosis Assoc., Tokyo, JPN)
Material： Respiratory Investigation  (Respir Investig)
Volume： 53  Issue： 6  Page： 288-295  Publication year： Nov. 2015 
JST Material Number： W2316A  ISSN： 2212-5345  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： *Pulmonary Fibrosis ,...
Semi thesaurus term： *Idiopathic Pulmonary Fibrosis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A1263778&from=J-GLOBAL&jstjournalNo=W2316A") }}

JST classification (3)： Drug therapy(=pharmacotherapy)for respiratory system diseases  (GI05020J) ,  Clinical application of drugs acting on respiration and respiratory system  (GW08020U) ,  Epidemiology  (GB03000E)

Substance index (1)： Ciclosporin

Reference (31)：

• American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-64.
• American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
• Borel JF, Feurer C, Gubler HU, et al. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 1976;6:468-75.
• Gruhn WB, Diaz-Buxo JA. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis. J Rheumatol 1987;14:1045-7.
• Alegre J, Teran J, Alvarez B, et al. Successful use of cyclosporine for the treatment of aggressive pulmonary fibrosis in a patient with rheumatoid arthritis. Arthritis Rheum 1990;33:1594-6.

Terms in the title (6)： 特発性肺線維症 ,  患者 ,  低用量 ,  コルチコステロイド ,  サイクロスポリンA ,  併用効果